Generic Drug Industry in Japan Market Research & Statistics

24/7 Customer Support

Talk to Sam

+1 718 473 0872

All regions

You might be interested in: generics, biosimilars, drug, more »

15 reports

Download Unlimited Documents from Trusted Public Sources

Generic Drugs Industry in Japan

  • Promotion of Use of Generic Drugs in Japan
  • July 2012
    15 pages
  • Generic Drugs  

  • Japan  

View report >

Pathology Description in Japan

  • Not for Distribution to Uk or us Media
  • January 2013
    3 pages
  • Cardiovascular ...  

  • Japan  

    United States  

    United Kingdom  

View report >

Biosimilars Market Forecast in Japan

  • Roland Berger Japanese Business Newsletter
  • January 2012
    4 pages
  • Biosimilars  

  • Japan  

    Asia  

View report >

Generic Drug Markets - Forecast

  • To Browse this Report Kindly Visit
  • January 2011
    5 pages
  • Generic Drug  

    Generics  

  • United States  

    Europe  

View report >

Global Generic Drug Market Revenue - Forecast

  • Business Highlights
  • January 2011
    9 pages
  • Generic Drug  

  • Japan  

    World  

    India  

View report >

Generics Industry in Japan

  • Japan's Generic Drug Market
  • May 2010
    18 pages
  • Generics  

  • Japan  

    Asia  

View report >

Generic Drug Industry in Japan

  • Original Article
  • January 2010
    7 pages
  • Generic Drug  

    Blood Supply, T...  

  • Japan  

View report >

The future of the Generic Drugs Industry in Japan

  • Generic Drug Business
  • January 2010
  • Generic Drugs  

  • Japan  

View report >

Medical Analysis in Japan

  • Increased Financial Burden among Patients with Chronic Myelogeno...
  • January 2009
    10 pages
  • Medical  

  • Japan  

View report >

Search in Generic Drug Industry

40 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 600 - $ 600)

Fesoterodine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Fesoterodine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

Frovatriptan - Patent, Extension And Data Exclusivity ...

August 2014 $ 653

Galantamine - Patent, Extension And Data Exclusivity E ...

August 2014 $ 653

Ibandronic Acid - Patent, Extension And Data Exclusivi ...

August 2014 $ 653

Imatinib - Patent, Extension And Data Exclusivity Expi ...

August 2014 $ 653

Lasofoxifene - Patent, Extension And Data Exclusivity ...

August 2014 $ 653

Pitavastatin - Patent, Extension And Data Exclusivity ...

August 2014 $ 653

Prasugrel - Patent, Extension And Data Exclusivity Exp ...

August 2014 $ 653

Rizatriptan - Patent, Extension And Data Exclusivity E ...

August 2014 $ 653

Valganciclovir - Patent, Extension And Data Exclusivit ...

August 2014 $ 653

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.